In-vitro Transcription Templates are necessary for in-vitro transcription, the in-vitro transcription is a procedure that uses bacteriophage DNA-dependent RNA polymerase to synthesize RNA of any sequence from a DNA template. n vitro transcription products include RNA production systems, nuclear extracts, ribonucleotides, cloning vectors and supporting products for transcription, primer extension and gene expression studies.

The global In-vitro Transcription Kits market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on In-vitro Transcription Kits volume and value at the global level, regional level and company level. From a global perspective, this report represents overall In-vitro Transcription Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global In-vitro Transcription Kits Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Yield Type
0-50 Rxns
50-100 Rxns
100+ Rxns

Segment by Application
Pharmaceutical & Biotechnology Companies
CROs
CMOs
Research Center
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Thermo Fisher Scientific, Inc.
Promega Corporation
Agilent Technologies, Inc.
New England Biolabs
Takara Bio Inc.
Lucigen Corporation
Enzynomics Co. Ltd.
Enzo Life Sciences, Inc.
Danaher